Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma

被引:0
作者
Xingjun Yao
Gang Zhao
Hongfa Yang
Xinyu Hong
Li Bie
Guojin Liu
机构
[1] The First Affiliated Hospital of Jilin University,Department of Surgery
来源
Journal of Cancer Research and Clinical Oncology | 2010年 / 136卷
关键词
HMGB1; Progression; Prognosis; Colorectal cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:677 / 684
页数:7
相关论文
共 133 条
[1]  
Choi YR(2003)Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation Cancer Res 63 2188-2193
[2]  
Kim H(2009)Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer J Transl Med 7 38-321
[3]  
Kang HJ(2001)Dual roles for HMGB1: DNA binding and cytokine J Endotoxin Res 7 315-234
[4]  
Kim NG(1995)Biology of human colon cancer metastasis World J Surg 19 226-19924
[5]  
Kim JJ(1999)Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways J Biol Chem 274 19919-100
[6]  
Park KS(2005)Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development Prostate 64 92-130
[7]  
Paik YK(2006)Cancer statistics, 2006 CA Cancer J Clin 56 106-258
[8]  
Kim HO(2004)Global gene expression profiles of human head and neck squamous carcinoma cell lines Int J Cancer 112 249-448
[9]  
Kim H(2003)Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer Oncol Rep 10 445-727
[10]  
Chung HW(2003)Differential effects between amphoterin and advanced glycation end products on colon cancer cells Int J Cancer 104 722-342